Edition:
United States

Stellar Biotechnologies Inc (SBOT.OQ)

SBOT.OQ on NASDAQ Stock Exchange Capital Market

1.04USD
11 Dec 2017
Change (% chg)

$-0.03 (-2.80%)
Prev Close
$1.07
Open
$1.07
Day's High
$1.08
Day's Low
$0.99
Volume
30,460
Avg. Vol
6,666
52-wk High
$2.21
52-wk Low
$0.99

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2016 Dec 0.49 -0.195
FY 2015 Sep '15 0.20 -0.193
Jun '15 0.16 0.100
Mar '15 0.19 -0.054
Dec 0.21 -0.169
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 186.11 35.51
P/E High - Last 5 Yrs. -- 274.30 45.27
P/E Low - Last 5 Yrs. -- 92.17 24.24
Beta 2.30 0.83 0.91
Price to Sales (TTM) 10.88 113.99 5.83
Price to Book (MRQ) 3.67 21.50 5.68
Price to Tangible Book (MRQ) 1.17 25.23 7.26
Price to Cash Flow (TTM) -- 101.64 24.44
% Owned Institutions -- 5.68 1.39

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.96 5.23
Payout Ratio(TTM) -- 95.86 45.95

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 129.55 -2.88 6.82
Sales (TTM) vs TTM 1 Yr. Ago 96.75 30.21 5.65
Sales - 5 Yr. Growth Rate -2.36 33.15 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -15.12 -147.47 7.23
EPS (TTM) vs TTM 1 Yr. Ago 34.56 -- --
EPS - 5 Yr. Growth Rate -- 43.45 10.90
Capital Spending - 5 Yr. Growth Rate 25.31 40.96 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 12.66 1.79 2.54
Current Ratio (MRQ) 13.39 5.75 3.56
LT Debt to Equity (MRQ) 0.00 14.45 13.23
Total Debt to Equity (MRQ) 0.00 16.90 19.24
Interest Coverage (TTM) -21.66 -147.16 44.55

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -2.51 43.05 54.80
Gross Margin - 5 Yr. Avg. -37.25 55.37 52.40
EBITD Margin (TTM) -402.15 -- --
EBITD - 5 Yr. Avg -925.62 -219.17 15.52
Operating Margin (TTM) -417.77 -631.99 6.76
Operating Margin - 5 Yr. Avg. -903.32 -236.03 11.03
Pre-Tax Margin (TTM) -299.28 -602.68 7.58
Pre-Tax Margin - 5 Yr. Avg. -1,297.44 -236.35 11.44
Net Profit Margin (TTM) -302.59 -600.25 3.81
Net Profit Margin - 5 Yr. Avg. -1,299.94 -239.62 7.73
Effective Tax Rate (TTM) -- 15.32 24.25
Effective Tax Rate - 5 Yr. Avg. -- 18.76 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 21,633,432 858,823,705
Net Income/Employee (TTM) -- -1,703,997 100,224,560
Receivable Turnover (TTM) 28.88 25.40 6.12
Inventory Turnover (TTM) 3.20 2.62 3.55
Asset Turnover (TTM) 0.09 0.42 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -26.32 -9.13 11.35
Return on Assets - 5 Yr. Avg. -96.24 0.30 12.32
Return on Investment (TTM) -32.77 -11.32 14.47
Return on Investment - 5 Yr. Avg. -121.29 3.50 16.13
Return on Equity (TTM) -33.17 -35.69 16.06
Return on Equity - 5 Yr. Avg. -235.84 5.92 17.32
  1 Year 3 Year 5 Year
Sales % 103.88 38.42 -2.36
EPS (TTM) % 67.90 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Stellar Biotechnologies Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.